𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508

✍ Scribed by Joseph I. Clark; James Moon; Laura F. Hutchins; Jeffrey A. Sosman; W. Martin Kast; Diane M. Da Silva; P. Y. Liu; John A. Thompson; Lawrence E. Flaherty; Vernon K. Sondak


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
146 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A Phase II trial of vinorelbine tartrate
✍ Robert P. Whitehead; James Moon; S. Spence McCachren; Evan M. Hersh; Wolfram E. πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Single‐agent chemotherapy with dacarbazine continues to be the standard of care for the treatment of metastatic melanoma. However, there is a large population of patients who have failed first‐line therapy and might benefit from additional treatment. In the current study,